Giapreza Injection
Product Images NDC 68547-501

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Giapreza (NDC 68547-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by La Jolla Pharmaceutical Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1ml-vial-carton (1 mL Vial Carton)

1ml-vial-carton (1 mL Vial Carton)
Giapreza (angiotensin II) Injection is a prescription medication used for intravenous infusion. It contains 2.5mg angiotensin II with inactive ingredients including mannitol, water for injection, and sodium hydroxide. It is packaged in single-dose vials of 1mL and should be diluted before administration. It is necessary to discard any unused portion of the vial. The medication should be stored in refrigeration between 2°C and 8°C (36°F and 46°F). This product is manufactured by the La Jolla Pharmaceutical Company located in San Diego, California.*
FDA Label Image

1ml-vial (1 mL Vial)

1ml-vial (1 mL Vial)
This text seems to be a label or package insert for a medication called dx3 containing angiotensin acetate, which should be stored between 2°C-8°C, and is supplied as a single-dose vial. It also includes information about a specific NDC (68547-501-02) and a reference to discarding any unused portion. It is unclear what the purpose of the medication is or how it should be administered.*
FDA Label Image

Giapreza Forest Plot

FDA Label Image

Giapreza Structure

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.